Consider two firms competing in a segment of the pharmaceutical industry. One firm, Totaltrip, is contemplating an investment in a new R & D lab. There is some probability of success associated with this new laboratory such that it will result in efficiencies that will lower the expected value of its variable cost of production. Totaltrip's only competitor, Greenleaf, does not have the resources to undertake a similar investment. Totaltrip's corporate financial planning staff has studied the proposed investment and reports that at current output levels, the present value of the expected cost savings from the investment is less than the cost of the project, but just barely so. Now, suppose that Totaltrip hires you as a consultant. You point out that a complete analysis would take into account the effect of the investment on the market equilibrium between Totaltrip and Greenleaf. What would this more complete analysis say about the desirability of this investment? Carefully detail your assumptions and analysis.